Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeEXECUTIVESJason Hollar New CFO of Cardinal Health

Jason Hollar New CFO of Cardinal Health

As Tenneco’s executive vice president and chief financial officer, Mr. Hollar was responsible for financial planning and analysis, accounting and reporting, tax, treasury and investor relations for the company.

Mr. Hollar joined Tenneco in June 2017 from Sears Holding Corporation, where he served as chief financial officer. Prior to Sears, Mr. Hollar worked with both Delphi Automotive and Navistar in a number of senior finance roles. He served as Delphi’s corporate controller and as vice president of finance for the company’s powertrain systems division, which also included oversight of the Europe, Middle East and Africa region. At Navistar, he held finance positions of increasing responsibility in the company’s engine group, South America operations and corporate financial planning and analysis.

Mr. Hollar received his Master of Business Administration from The University of Chicago and his bachelor’s degree in business from Indiana University.

“We are pleased to welcome Jason to the Cardinal Health family,” said Cardinal Health CEO Mike Kaufmann. “With his deep executive experience, as well as his expertise leading in dynamic environments, Jason will be a strong partner to me and the rest of our team. I’d like to thank Dave Evans for his exceptional contributions and leadership as our interim CFO. Dave will partner with Jason in the coming weeks to ensure a smooth transition and as we continue to create value in a changing marketplace.”

Mr. Hollar’s experience spans industries and geographies. In addition to serving as CFO of Tenneco and previously as CFO of Sears Holding Corporation, Mr. Hollar held senior finance roles at companies including Delphi and Navistar, demonstrating both breadth and depth across financial disciplines. He also managed regional operations around the globe and led multiple transformative initiatives to drive corporate strategies.

As Cardinal Health CFO, Mr. Hollar will lead financial activities across the enterprise, including financial strategy, capital deployment, treasury, tax, investor relations, accounting and reporting. He will report to Mr. Kaufmann as a member of the company’s Executive Committee and will succeed Dave Evans, who will continue to serve as CFO of Cardinal Health through May 11.

I am excited to join the Cardinal Health team,” said Mr. Hollar. “I look forward to partnering with Mike, his leadership team and the Finance organization to advance the company’s strategic transformation at this pivotal time in healthcare.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy